
Emmaus Life Sciences Inc (QB) (EMMA)
USOTC
Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease. Emmaus Life Sciences, Inc. is a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease.
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0037 | 21.1428571429 | 0.0175 | 0.0212 | 0.015 | 15977 | 0.01744523 | CS |
4 | -0.0085 | -28.6195286195 | 0.0297 | 0.047 | 0.01 | 60870 | 0.0233941 | CS |
12 | 0.0062 | 41.3333333333 | 0.015 | 0.047 | 0.0039 | 68500 | 0.01785951 | CS |
26 | 0.0192 | 960 | 0.002 | 0.0499 | 0.002 | 50896 | 0.0214013 | CS |
52 | -0.0904 | -81.0035842294 | 0.1116 | 0.129 | 0.0001 | 44720 | 0.02208239 | CS |
156 | -1.4288 | -98.5379310345 | 1.45 | 1.45 | 0.0001 | 31829 | 0.18126384 | CS |
260 | -1.3788 | -98.4857142857 | 1.4 | 4 | 0.0001 | 25613 | 0.59882373 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約